Amgen
Tracked across 22 events · 627 articles · First seen Mar 09, 2018 · Last active Aug 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Amgen voluntarily recalled nearly one million bottles of its Corlanor and Sensipar tablets due to the presence of a foreign substance, impacting its product distribution and potentially its reputation, though the health risk is deemed low.
Jun 27, 2026 · 6 articles
Accidents
Impact: Amgen is the primary victim, facing potential regulatory fines, legal liabilities, and reputational damage from the breach. The company is managing the incident and assessing the full scope of data exposure.
Jul 31, 2026 · 6 articles
Business
Amgen announced plans to establish a new Science and Innovation Centre at India — Genome Valley in Hyderabad, India, as part of its global R&D network. The facility, expected to be operational in 2027, will…
Impact: Amgen is the primary actor, announcing a new R&D center that expands its global research network and integrates science with technology, potentially accelerating drug development.
Aug 11, 2026 · 6 articles
Business
Impact: Amgen, along with its subsidiary Teneobio, was found by a jury to have willfully infringed Harbour BioMed's patent, resulting in a $20.2 million damages award against them, with potential for trebling to $60.6 million. This verdict negatively impacts Amgen's reputation and financial standing.
Jun 15, 2026 · 6 articles
Business
Impact: Amgen is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Regulatory
Impact: Amgen acquired ChemoCentryx in 2022, and as such, the revocation of the EU marketing authorization for TAVNEOS, a drug developed by ChemoCentryx, will have an indirect negative impact on Amgen.
Jun 26, 2026 · 9 articles
Regulatory
Impact: Competitor with injectable PCSK9 inhibitor Repatha; faces potential market share loss to oral alternative.
Jul 16, 2026 · 93 articles
Tech
Impact: Amgen>>> is among global drugmakers deploying AI to identify trial participants more quickly and cut time for drug safety reports, potentially saving millions of dollars.
May 28, 2026 · 6 articles
Business
Impact: Amgen's Repatha is a competitor to Scribe's STX-1150 in the PCSK9 inhibitor space. The success of Scribe's therapy could impact Amgen's market share in cholesterol management.
Jul 06, 2026 · 25 articles
Regulatory
Impact: Amgen is one of the leading life sciences companies that has established or expanded R&D, digital, and global capability centers in Hyderabad, reflecting confidence in India — Telangana's ecosystem.
Jan 21, 2026 · 6 articles
Business
Impact: Rajani Dinavahi spent seven years at Amgen, contributing to multiple global development programs.
Apr 01, 2026 · 6 articles
Business
Impact: Laura Hamill spent nearly two decades at Amgen, where she held roles of increasing responsibility, including Senior Vice President, U.S. Commercial Operations.
Jun 15, 2026 · 6 articles
Business
Impact: Andrew Gengos was Vice President of Strategy and Corporate Development at Amgen for eight years.
Jun 15, 2026 · 6 articles
Tech
Impact: One author disclosed ties to Amgen, which is a minor detail in the context of the overall study findings.
Jun 15, 2026 · 6 articles
Business
Impact: Amgen>>> owns the trademarks for Prolia and Xgeva, the reference products for Alvogen>>>'s AVT03 biosimilar. While not directly related to the current resubmissions, it highlights the competitive landscape Alvogen>>> operates in.
Jun 04, 2026 · 10 articles
Business
Impact: Amgen Inc. is an early user and collaborator with Quantinuum, demonstrating the practical application of Quantinuum's quantum computing platforms.
May 26, 2026 · 76 articles
Business
Impact: Amgen is mentioned as a previous employer of Dr. Zack, where she served as Global Development Lead for Enbrel.
Jul 27, 2026 · 6 articles
International
Iran and Oman have been negotiating a deal to manage shipping through the Strait of Hormuz, which Iran has largely closed since the US-Israel war began in February. The proposed agreement would give Iran control…
Impact: Amgen's stock rose on strong sales, contributing to the Dow's gains. It is unrelated to the Hormuz situation.
Mar 09, 2018 · 316 articles
100
Amgen announced plans to openAmgen opens Hyderabad...
80
Amgen signed MoU India — TelanganaAmgen opens Hyderabad...
60
Amgen reported salesIran-Oman Strait of Hormuz...
ERGEN INTELLIGENCE
Track Amgen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard